Tocilizumab for Silicone Oil-Induced Recalcitrant Cystoid Macular Edema in a Patient with Recurrent Acute Retinal Necrosis-Associated Retinal Detachment
This case represents the first documented successful use of tocilizumab in treating silicone oil-induced recalcitrant cystoid macular edema. When silicone oil cannot be removed from an eye and when steroids risk reactivating viral retinal disease, tocilizumab may offer a safe and effective treatment alternative for such macular edema.
Authors
- Jason Miller
- Jacqueline A. Madison (ORCID: https://orcid.org/0000-0003-1745-8133)
- Thomas J. Wubben (ORCID: https://orcid.org/0000-0002-5183-3817)
- Shilpa Kodati (ORCID: https://orcid.org/0000-0002-9690-5319)
- Mahsaw Mansoor (ORCID: https://orcid.org/0000-0002-4086-2129)
- Warren W. Pan (ORCID: https://orcid.org/0000-0003-4931-8864)
- David Riccardi
Institutions
- University of Michigan (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1080/09273948.2025.2519849
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation Fighting Blindness
- Research to Prevent Blindness